openPR Logo
Press release

Artemisinin Combination Therapies Market 2025 | Enhanced Surveillance Supports Growth | Major Companies - Novartis AG, Ajanta Pharma, Shinpoong Pharm.co., Ltd, Schwitz Biotech, Stravahealthcare, Enzymes Pharmaceuticals

06-12-2025 07:59 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Artemisinin Combination Therapies Market

Artemisinin Combination Therapies Market

Global Artemisinin Combination Therapy Market reached US$ 547 million in 2023 and is expected to reach US$ 1,061 million by 2031, growing at a CAGR of 8.8% during the forecast period 2024-2031.

Artemisinin Combination Therapy Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/artemisinin-combination-therapy-market?ca

Artemisinin Combination Therapy (ACT) is the standard treatment for uncomplicated *Plasmodium falciparum* malaria, combining fast-acting artemisinin with a longer-acting partner drug to enhance efficacy and reduce the risk of resistance. ACT rapidly clears parasites from the bloodstream, alleviates symptoms, and helps prevent transmission. It is widely recommended by the World Health Organization (WHO) due to its high cure rates and role in combating drug-resistant malaria strains.

Major players in the Artemisinin Combination Therapy market

The prominent players in Artemisinin Combination Therapy market research report are: Novartis AG, Ajanta Pharma, Shinpoong Pharm.co., Ltd, Schwitz Biotech, Stravahealthcare, Enzymes Pharmaceuticals, Wellona Pharma, Saphnix Life Sciences, Centurion Laboratories Private Limited and SiNi Pharma Pvt Ltd

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Artemisinin Combination Therapy Market Dynamics

The high prevalence of malaria in developing and underdeveloped countries is driving the growth of the artemisinin combination therapy (ACT) market. ACTs are the WHO-recommended first-line treatment for uncomplicated malaria and are crucial in endemic regions. According to the 2022 World Malaria Report, malaria cases rose to 249 million, highlighting the ongoing need for effective therapies and boosting market demand.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/artemisinin-combination-therapy-market?ca

Artemisinin Combination Therapy Market Segments

By Combination Therapy Type: Artemether-Lumefantrine, Artesunate-Amodiaquine, Artesunate-Pyronaridine, Artesunate-Sulfadoxine-Pyrimethamine, Others

By End-User: Hospital, Clinics, Research Centers, Others

The Artemisinin Combination Therapy industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Artemisinin Combination Therapy Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artemisinin Combination Therapies Market 2025 | Enhanced Surveillance Supports Growth | Major Companies - Novartis AG, Ajanta Pharma, Shinpoong Pharm.co., Ltd, Schwitz Biotech, Stravahealthcare, Enzymes Pharmaceuticals here

News-ID: 4062847 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Automatic Packaging Robot Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
United States Automatic Packaging Robot Market 2025 | Industry Developments, Fut …
Automatic Packaging Robot Market reached US$ 4.0 billion in 2023 and is projected to reach US$ 10.2 billion by 2031, growing at a CAGR of 12.4% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Automatic Packaging Robot Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and
Human Augmentation Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
Human Augmentation Market 2025 | Industry Developments, Future Growth, Share & I …
The Human Augmentation Market reached US$ 252.6 billion in 2023 and is projected to reach US$ 780.7 billion by 2031, growing at a CAGR of 15.6% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Human Augmentation Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging
Learning Management System (LMS) Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
Learning Management System (LMS) Market 2025 | Industry Developments, Future Gro …
Learning Management System (LMS) Market reached US$ 18.7 billion in 2023 and is projected to reach US$ 67.2 billion by 2031, growing at a CAGR of 17.7% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Learning Management System Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts,
Team Collaboration Tools Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
Team Collaboration Tools Market 2025 | Industry Developments, Future Growth, Sha …
The Team Collaboration Tools Market reached US$ 23.3 billion in 2023 and is projected to reach US$ 62.8 billion by 2031, growing at a CAGR of 13.5% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Team Collaboration Tools Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts,

All 5 Releases


More Releases for Combination

Advancements in Cancer Combination Therapy
Cancer combination therapy, which involves the use of multiple therapeutic agents, has revolutionized cancer treatment in recent years. This approach leverages the strengths of different therapies to enhance efficacy, reduce toxicity, and overcome drug resistance, leading to better patient outcomes.The concept of combination therapy is not new. It has been used successfully in treating infectious diseases and some chronic conditions. However, its application in cancer therapy has seen significant advancements
Combination Vaccines Market Green and Efficient: The Future of Immunization with …
Combination Vaccines Market to reach over USD 10.11 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Combination Vaccines Market Size, Share & Trends Analysis Report By Technology (Conjugate, Live, Inactivated), Age Group (Pediatric, Adult), Application (Diphtheria, Tetanus, & Pertussis (DTP), Polio, Hepatitis B, Influenza), End-use (Hospitals, Clinics), Region, Market Outlook And Industry Analysis
Combination of light and shade
Designer awning for glass canopies mesmerises with fantastic accentuated lighting Underglass awnings are perfect for patio roofs and conservatories. Because under a glass canopy, they have plenty of protection. One new model is the "markilux 679". It has clean lines in its design, provides plenty of shade and creates a beautiful interplay of light on the patio with its LED lights. Unlike above-glass awnings, underglass awnings are fixed under a glass canopy.
Combination of light and shade
Underglass awning by markilux combines clean design with effective LED technology The "markilux 679" is a new form of solar protection for patio roofs and conservatories. The awning has a modern cubic shape, offers plenty of shade and, with LED Lines controlled by an app, ensures an attractive interplay of light on both the cover and façade of the house. Underglass awnings are perfect for both patio roofs and conservatories. The cover,
Combination Hypertension Agents Market - Maximum Impact on Blood Pressure: Combi …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Combination Hypertension Agents Market. Combination Hypertension Agents Market: https://www.growthplusreports.com/report/combination-hypertension-agents-market/9169 The Combination Hypertension Agents Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Fixed-Dose Combination Drugs Market - Leading Innovation in Combination Drug Del …
Newark, New Castle, USA - new report, titled Fixed-Dose Combination Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Fixed-Dose Combination Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Fixed-Dose Combination Drugs market. The report offers an overview of